Alunbrig in India

1
Alunbrig Know its Mechanism of action and how it
should be taken
Alunbrig (brigatinib) is a potent and selective
next-generation tyrosine kinase inhibitor (TKI)
designed to target molecular alterations in
anaplastic lymphoma kinase (ALK).
2
Alunbrig in India
Talk to professional sources that are well versed
with the Indian regulatory requirements and
specifications. Ariad Pharmaceuticals, a
subsidiary of Takeda Pharmaceutical Company
Limited, developed Brigatinib, which was approved
by the FDA on April 28, 2017.
3
Visit Us https//synergydrugs.com/
Brigatinib is a tyrosine kinase inhibitor with
clinically achievable in vitro activity against
multiple kinases, including ALK, ROS1,
insulin-like growth factor-1 receptor (IGF-1R),
and FLT-3, as well as EGFR deletion and point
mutations.
4
Alunbrig in India
Brigatinib also reduced tumor burden and extended
survival in mice with an ALK-driven tumor cell
line implanted intracranially. This drug is
available in three strengths 30mg, 90mg and
180mgand the only way to have Alunbrig in India
is through import route.
5
Visit Us https//synergydrugs.com/
Take Alunbrig exactly as directed by your
healthcare provider. If your healthcare provider
tells you to, don't change your dose or stop
taking Alunbrig. For the first 7 days of
treatment, your healthcare provider will start
you on a low dose of Alunbrig (90 mg). After the
first seven days of treatment, if you tolerate
this dose of Alunbrig well, your healthcare
provider may increase your dose.
6
Alunbrig Know its Mechanism of action and how it
should be taken
Email Us access_at_synergydrugs.com   Call Us 91
9677010046   Visit Us https//synergydrugs.com/